T80.810

Clinical Causes: Accidental leakage of chemotherapy drugs during intravenous administration Inexperienced administration techniques Fragile or damaged blood vessels making them prone to leakage Poor securing or monitoring of IV lines during treatment Misplacement or dislodgment of the IV catheter

Key Symptoms: Pain or burning sensation at the infusion site Swelling around the IV site Redness and warmth in the affected area Blistering or skin necrosis in severe cases Discoloration or hardening of the tissue Possible systemic symptoms if the drug enters the bloodstream in significant amounts

Diagnosis Path: Diagnosis is primarily based on clinical observation during or after chemotherapy infusion. Healthcare providers assess for signs of infiltration, such as swelling, pain, or skin changes. Imaging studies like ultrasound may be used to evaluate the extent of tissue involvement in complex cases. Documentation of the infusion process and the site is critical for confirming extravasation.

Treatment Protocols: Treatment depends on the type and amount of the vesicant drug extravasated, as well as the severity of tissue injury. Approaches may include: - Immediate cessation of the infusion to prevent further tissue damage - Applying cold or warm compresses as appropriate to reduce inflammation and pain - Aspirating any residual drug from the tissue if possible - Administering antidotes or neutralizing agents specific to the chemotherapy drug involved - Elevating the affected limb to reduce swelling - Surgical consultation in cases of severe tissue necrosis, which might necessitate debridement or skin grafting - Close monitoring and supportive care to promote healing and prevent complications Prevention strategies emphasize careful IV insertion, constant monitoring during infusion, and staff training to recognize early signs of extravasation.